{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:07:20Z","timestamp":1790222840596,"version":"4.1.0"},"reference-count":25,"publisher":"Informa UK Limited","issue":"16","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Bioanalysis"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.4155\/bio.14.191","type":"journal-article","created":{"date-parts":[[2014,10,21]],"date-time":"2014-10-21T11:20:21Z","timestamp":1413890421000},"page":"2125-2133","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":43,"title":["Quantification of Amikacin and Kanamycin in Serum Using A Simple and Validated LC\u2013MS\/MS Method"],"prefix":"10.1080","volume":"6","author":[{"given":"Jacob A","family":"Dijkstra","sequence":"first","affiliation":[{"name":"University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy &amp; Pharmacology, PO Box 30.001, 9700RBGroningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke GG","family":"Sturkenboom","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy &amp; Pharmacology, PO Box 30.001, 9700RBGroningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai van","family":"Hateren","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy &amp; Pharmacology, PO Box 30.001, 9700RBGroningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco A","family":"Koster","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy &amp; Pharmacology, PO Box 30.001, 9700RBGroningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Greijdanus","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy &amp; Pharmacology, PO Box 30.001, 9700RBGroningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Willem C","family":"Alffenaar","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy &amp; Pharmacology, PO Box 30.001, 9700RBGroningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,10,21]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1205429"},{"key":"e_1_3_3_4_1","first-page":"84","volume-title":"Treatment of Tuberculosis Guidelines","author":"World Health Organization","year":"2010","unstructured":"World Health Organization . Group of drugs to treat MDR-TB. In:Treatment of Tuberculosis Guidelines. WHO Press, Switzerland, 84 (2010)."},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00240-10"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1086\/321854"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-004-1109-5"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1086\/420742"},{"issue":"1","key":"e_1_3_3_9_1","first-page":"3","article-title":"Prevention and modulation of aminoglycoside ototoxicity (Review)","volume":"1","author":"Perletti G","year":"2008","unstructured":"Perletti G , VralA, PatrossoMCet al. Prevention and modulation of aminoglycoside ototoxicity (Review). Mol. Med. Rep. 1 (1), 3\u201313 (2008).","journal-title":"Mol. Med. Rep"},{"issue":"7","key":"e_1_3_3_10_1","first-page":"622","article-title":"Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis","volume":"6","author":"de Jager P","year":"2002","unstructured":"de Jager P , van AltenaR. Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis. Int. J. Tuberc. Lung Dis. 6 (7), 622\u2013627 (2002).","journal-title":"Int. J. Tuberc. Lung Dis"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.9.1383"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262150-00001"},{"key":"e_1_3_3_13_1","article-title":"WHO","author":"Stop TB Partnership","year":"2015","unstructured":"Stop TB Partnership . WHO. The Global Plan to Stop TB 2011\u20132013 (2015).","journal-title":"The Global Plan to Stop TB 2011\u20132013"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(04)01570-5"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-009-3263-1"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.11.135"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt154"},{"key":"e_1_3_3_18_1","unstructured":"US Department of Health and Human Services Food and Drug Administration . Guidance for Industry Bioanalytical Method Validation. Center for Drug Evaluation and Research Rockville MD USA (2001)."},{"key":"e_1_3_3_19_1","unstructured":"European Medicines Agency Committee for Medicinal Products for Human Use . Guideline on Bioanalytical Validation (EMEA\/CHMP\/EWP\/192217\/2009). European Medicines Agency London UK (2011)."},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.1276"},{"key":"e_1_3_3_21_1","first-page":"5","article-title":"A rapid and simple liquid chromatography-tandem mass spectrometry method for the determination of linezolid in human serum","volume":"14","author":"Harmelink IM","year":"2008","unstructured":"Harmelink IM , AlffenaarJWC, WesselsAMA, GreijdanusB, UgesDRA. A rapid and simple liquid chromatography-tandem mass spectrometry method for the determination of linezolid in human serum. Eur. J. Hosp. Pharm. 14, 5\u20138 (2008).","journal-title":"Eur. J. Hosp. Pharm"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2009.04.038"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/34.3.135"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis270"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161211797470174"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01054-12"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2011.03.017"}],"container-title":["Bioanalysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/bio.14.191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T17:56:48Z","timestamp":1715968608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/bio.14.191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":25,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.4155\/bio.14.191"],"URL":"https:\/\/doi.org\/10.4155\/bio.14.191","relation":{},"ISSN":["1757-6180","1757-6199"],"issn-type":[{"value":"1757-6180","type":"print"},{"value":"1757-6199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-10-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}